Background: Survival of people with HIV-2 and HTLV-1 infection is better than that of HIV-1 infected people, but long-term follow-up data are rare. We compared mortality rates of HIV-1, HIV-2, and HTLV-1 infected subjects with those of retrovirus-uninfected people in a rural community in Guinea-Bissau. Methods: In 1990, 1997 and 2007, adult residents (aged ≥15 years) were interviewed, a blood sample was drawn and retroviral status was determined. An annual census was used to ascertain the vital status of all subjects. Cox regression analysis was used to estimate mortality hazard ratios (HR), comparing retrovirus-infected versus uninfected people. Results: A total of 5376 subjects were included; 197 with HIV-1, 424 with HIV-2 and...
SETTING: Randomised controlled clinical trial of Mycobacterium vaccae vaccination as an adjunct to a...
Background: Hepatitis B has been reported to be high in HIV-infected African populations. However, t...
Mortality in HIV-infected patients who have access to highly active antiretroviral therapy (ART) has...
Background: Survival of people with HIV-2 and HTLV-1 infection is better than that of HIV-1 infect...
Survival of people with HIV-2 and HTLV-1 infection is better than that of HIV-1 infected people, but...
ABSTRACT: BACKGROUND: In Guinea-Bissau HIV-1, HIV-2, and HTLV-I are prevalent in the general populat...
Background: HTLV-1 is endemic in Guinea-Bissau, and the highest prevalence in the adult population...
Background: HIV type 2 (HIV-2) is considered more benign and has fewer pathogenic consequences than ...
Background HIV type 2 (HIV-2) is considered more benign and has fewer pathogenic consequences than H...
BACKGROUND: There have been no previous studies of the long-term survival and temporal changes in pl...
Human T-lymphotropic virus type I (HTLV-I) provirus load was examined in a cohort of a population in...
AbstractObjectivesTo investigate the effect of human T-lymphotropic virus type 1 (HTLV-1) on CD4 cou...
Early mortality of HIV/HBV-coinfected individuals on ART is very high in SSA, especially in rural s...
BACKGROUND: HTLV-1 is endemic in Guinea-Bissau, and the highest prevalence in the adult population (...
OBJECTIVE: To examine mortality differentials in HIV-infected and uninfected adults by demographic c...
SETTING: Randomised controlled clinical trial of Mycobacterium vaccae vaccination as an adjunct to a...
Background: Hepatitis B has been reported to be high in HIV-infected African populations. However, t...
Mortality in HIV-infected patients who have access to highly active antiretroviral therapy (ART) has...
Background: Survival of people with HIV-2 and HTLV-1 infection is better than that of HIV-1 infect...
Survival of people with HIV-2 and HTLV-1 infection is better than that of HIV-1 infected people, but...
ABSTRACT: BACKGROUND: In Guinea-Bissau HIV-1, HIV-2, and HTLV-I are prevalent in the general populat...
Background: HTLV-1 is endemic in Guinea-Bissau, and the highest prevalence in the adult population...
Background: HIV type 2 (HIV-2) is considered more benign and has fewer pathogenic consequences than ...
Background HIV type 2 (HIV-2) is considered more benign and has fewer pathogenic consequences than H...
BACKGROUND: There have been no previous studies of the long-term survival and temporal changes in pl...
Human T-lymphotropic virus type I (HTLV-I) provirus load was examined in a cohort of a population in...
AbstractObjectivesTo investigate the effect of human T-lymphotropic virus type 1 (HTLV-1) on CD4 cou...
Early mortality of HIV/HBV-coinfected individuals on ART is very high in SSA, especially in rural s...
BACKGROUND: HTLV-1 is endemic in Guinea-Bissau, and the highest prevalence in the adult population (...
OBJECTIVE: To examine mortality differentials in HIV-infected and uninfected adults by demographic c...
SETTING: Randomised controlled clinical trial of Mycobacterium vaccae vaccination as an adjunct to a...
Background: Hepatitis B has been reported to be high in HIV-infected African populations. However, t...
Mortality in HIV-infected patients who have access to highly active antiretroviral therapy (ART) has...